Is Torture a Good Idea?
Channel 4, 28 February at 8 pm Rating: ★★★★ E ver wondered what it's like to be detained in Guantanamo Bay? Seven British volunteers, including several Muslims, were given the chance to find out, courtesy of Channel 4, as part of a week-long series of programmes on torture. Reporting to a specially equipped warehouse, they were ambushed, hooded, kidnapped, shackled, caged, and subjected to a range of Pentagon approved interrogation techniques that included sensory deprivation, "sleep adjustment," religious and sexual humiliation, and severe physical pain. But Torture: The Guantanamo Guidebook was no Big Brother-style reality show. This was a serious attempt to examine the effects of torture on the body and the psyche, and to bring home to viewers the kind of interrogation techniques that are being employed in the US-led so called "war on terror." "Tonight we recreate 48 hours in Guantanamo Bay," announced presenter Jon Snow, better known as the face of Channel 4 News. "All the interrogation methods you see have been officially sanctioned by the US government and used to fight the war on terror." Using military manuals and declassified US government documents, Channel 4 had installed cages, interrogation rooms, and surveillance equipment to simulate Guantanamo's conditions and methods. But the volunteers, who had their own clothes torn and cut off and replaced with the trademark orange boiler suit, could not experience the full horror of the real Guantanamo, where the detainees range from teenagers to the elderly. "That would be too dangerous," said Snow. So, if the real Guantanamo practises what US defence secretary Donald Rumsfeld has described as "torture lite," then this was going to be "torture lite" lite. Hardly.
Snow warned us, "What you are about to see is both shocking and upsetting." And so it was. Channel 4's torturers were a squad of former US army guards and interrogators, and definitely not to be messed with. These men seemed to know what they were doing. They had all the moves, the taunts, the carefully targeted sadism. They knew about short shackling, about stress positions, about subjecting detainees to white noise and uncomfortably hot and cold extremes (known, euphemistically, as "environmental manipulation"), and about what is termed "scenery up, scenery down"-making detainees move cells to disorient them and stop them making friends with their adjacent cellmates. They forced volunteers to urinate in their boiler suits. And they knew well what physical effects to expect from all this.
The temperature in the cells was kept at 6 o C. One volunteer, a 49 year old, who at the start of the programme had said that he approved of what was happening at Guantanamo, soon had to be withdrawn as he was suffering from hypothermia.
Could such methods ever be justified in a world post September 11, Snow asked. The programme did not answer this directly, but let the volunteers-who were visibly distressed, even though they knew it was all an experiment-give their own verdicts. Two pulled out before the end, including an Oxford student of dual American and British citizenship who had originally said that the ends could justify the Guantanamo means but who, after his "Guantanamo" ordeal (which at one stage made him vomit in his cage), felt that such methods were unacceptable. His fellow detainees were equally critical of "torture lite," including one other who had previously thought there was a case for it.
This was the sort of programme that made me wonder why we aren't all marching in the streets demanding regime change on either side of the Atlantic-especially given that there is no independent evidence that what is happening at Guantanamo and US torture centres elsewhere in the world has so far prevented any terrorist attacks.
This idea was further explored in the earlier programme, Is Torture a Good Idea?
The British lawyer Clive Stafford-Smith, who has spent 20 years defending prisoners on death row in the American Deep South, set out to explore the question "Does torture work?" Stafford-Smith has also represented British prisoners held at Guantanamo and he described visiting them as "worse than visiting death row." "How can America have come to this?" he asked (but some might say that a country that imprisons almost 1% of its people has shown form).
Stafford-Smith interviewed people who had experienced torture from both sides, including a former CIA officer and some British expatriates who were tortured by the Saudis and then confessed to a murder that they hadn't committed. The message was clear: there is no evidence at all that torture is anything other than a completely pointless activity. One torture victim said, "I'll tell them anything they want to hear." As Stafford-Smith discovered, the torturer doesn't get the truth but gets what he wants to hear from the person he is abusing, and governments don't get the intelligence gold dust that would compensate for the public relations catastrophe of places such as Guantanamo.
Doctors are of course among those who are left to pick up the pieces once the torturers have made their marks. Since it was founded in 1985-6, the UK Medical Foundation for the Care of Victims of Torture has had more than 38 000 survivors referred to it for help. Given that the UK and US governments are now aping the behaviour of the tinpot dictators they so publicly decry, that number looks likely to swell. 
Trevor Jackson

T
he Science Museum's latest exhibition defines its subject as the active making, manipulation, and measurement of extremely tiny things. These things are measured in nanometres, with a nanometre being a millionth of a millimetre, or about as far as a fingernail grows in a second.
At the nanoscale, materials behave differently, and it's their weird and wonderful properties that nanotechnology sets out to exploit. Increased reactivity is one such property-a function of the increased ratio of an object's surface area to its volume as it gets smaller. For example, nanoparticles of silver are more reactive than large particles. Attached to cotton fabric, nanoparticles stop bacteria and fungi growing, hence their use in wound dressings and non-smell socks.
Most medical uses of nanotechnology, however, are hypothetical. What research has been done, warns the exhibition, is at an early stage, and interventions will have to undergo rigorous trials before entering clinical practice.
Three possible uses are highlighted: delivering the exact dose of a drug to the intended location, providing new ways to grow and repair body tissues, and using the detection of single molecules in diagnosis. In this diagnostic use, a single strand of DNA, wrapped around a carbon nanotube, recognises other molecules and sends an electronic signal down the carbon nanotube, which transfers the signal to a computer. "Hype or hope?" asks the commentary, and then answers its question: "Tiny sensors under your skin could be sensitive enough to detect one warning molecule in your blood and may eventually be able to send that information direct to your GP's surgery." Mercifully, we're spared a Fantastic Voyage-like nano-submarine on a mission to dissolve a clot.
The inclusion of the words "big deal" in the exhibition's title is presumably aspirational. As a recent Economist survey of nanotechnology pointed out, there's something of an "intellectual-property land-grab" going on, with more investment capital sloshing around than there are good ideas to fund, and a host of countries with significant stakes in nanotechnology research (www.economist.com/surveys/showsurvey. cfm?issue = 20050101). The UK Department of Trade and Industry, ever mindful of the financial interests of UK plc, part funded the exhibition and chose its opening day to publish its response to Nanoscience and Nanotechnologies: Opportunities and Uncertainties. Commissioned from the Royal Society and the Royal Academy of Engineering, this report sought to ensure the provision of a regulatory system that would address public concerns and would allow the development of nanotechnologies in a respectable and innovative way.
Nanotechnology is not without its risks, although like its medical benefits, these are mostly theoretical at this stage. To its credit the exhibition doesn't flinch from documenting these, even going to the extent of including an electron micrograph showing carbon nanotubes that have found their way into human skin cells.
Nanoparticles have probably existed since the world began-they're present in volcanic ash, smoke, and even the ocean spray. But this doesn't help us when it comes to manmade nanoparticles, or "natural" nanoparticles in unnaturally high concentrations.
Tony Delamothe web editor, bmj.com tdelamothe@bmj.com
To Kill and Kill Again-Dr Shipman ITV 1, 1 March at 9 pm Rating: ★★★ T here are several reasons why murderers are able to kill over long periods. The commonest circumstance is that deaths are not identified as murders, or not connected with one another. Some prey on groups at the edge of society, whose disappearances are not noticed. Fred and Rose West concealed the bodies of their victims, so no murder investigations were launched. Some killers in countries with more population mobility or less developed law enforcement kill for years before detection because deaths are not identified as having one source. In some cultures, the very idea of a serial killer was regarded as impossible and political changes were required before the possibility could be considered. Other murderers are mobile, and leave a trail of apparently unconnected deaths.
The general practitioner Harold Shipman combined many of these features, while killing in full view. He often murdered people whose deaths, while unexpected, did not appear unlikely. The youngest person whose death was regarded as suspicious by the Shipman inquiry, a 4 year old in hospital, was seriously ill. In other people he created the impression that the death was plausible by manipulating their records, diagnosis, and family understanding of their prognosis. He created the circumstances in which he could continue to kill by moving to a singlehanded practice when increased scrutiny seemed probable. There was no cultural appreciation that a doctor might murder on this scale.
This programme did a competent job of documenting Shipman's dishonesty, manipulations, and murder. It was billed as focusing on an attempt to understand Shipman's activities and, on this level, it was less successful. Four psychiatrists advised the Shipman inquiry, but none appeared in the unfinished preview tape (and anyway, they had felt unable to come to a clear conclusion on Shipman's motivation). The commentators in the programme were thrown back on generalities.
In common with many serial murderers, Shipman's activities escalated in the final years. During an abortive police investigation, Shipman suspended his activities, before committing three final murders. His last murder included a bungled attempt at fraud. No previous murder had been associated with a sustained attempt at material gain.
Shipman maintained control in the police investigation until confronted with overwhelming computer evidence of altered records. The interview was paused. Harold Shipman was reported to be extremely distressed in the presence of his lawyer, crawling on hands and knees, weeping. He made no subsequent responses to police questions, other than "no comment."
This cycle of loss of control, decreasing frequency between murders, acts likely to lead to identification, and final overwhelming distress when cornered, are familiar from other killers. Shipman was special only for the number of people he murdered. Considering him in the context of other murderers probably offers the best chance of gaining any limited understanding of his actions. It is refreshing to read about the marvellous range of mechanisms by which viruses are selected to survive and flourish in a variety of hosts and environments. As the human population increases, encroaching on the natural habitats of other species, exposure of humans to viruses carried by wild animals will increase. We can only hope that knowledge of viruses' survival mechanisms will yield clues to ways we can limit their harm to us.
Cameron Stark consultant in public health, NHS
Many people know that after Koch thought he had established Vibrio cholerae as the cause of cholera a sceptical colleague drank a culture without ill effect. Clearly there was more to it: an X factor was at work. This proved to be not one but two bacterial viruses. One induces the bacterium to produce a receptor for the bacteriophage so that it can enter the bacterial cell; the second phage codes for the cholera toxin that causes the watery diarrhoea. If drinking water is kept free of the V cholerae infected with the phage all is well, just as phage and bacterium live harmlessly together in zooplankton infested coastal waters of the Pacific.
At the other extreme is HIV, which almost certainly came from infection in chimpanzees and eventually was able to pass from human to human, aided in this process by reverse transcriptase, an enzyme that converts viral RNA to DNA and enables it to integrate into the host cell's DNA and thus to survive for as long as the host lives. The book considers the possibility of controlling the disease through live attenuated virus, exploiting the phenomenon called superinfection interference. Attenuated monkey virus quickly establishes durable immunity covering a wide range of antigenic variants. The protection seems to result from interference, as it cannot be passively transferred to normal monkeys by serum antibodies and seems not to involve immune cells. Reversion to virulence is, of course, a problem, but Goudsmit clearly thinks it is an approach worth pursuing. This is a good read but will be hard going for the lay readers for whom it is written. The author, unfortunately, often ascribes human qualities to viruses, whereas he knows that survival depends on a high rate of replication and mutation to provide candidates to fit the challenge of the ever changing environment. The importance of research underpins the whole of this movie about Kinsey's life and work. Cast members were required to learn about Kinsey, his study team, and his methods for taking sexual histories. Director Bill Condon decided to mirror Kinsey's interviewing technique "as a way into Kinsey's personal biography," so the film is matter of fact about issues to do with sex, including Kinsey's own relationships and particularly his bisexuality.
Kinsey (played by Liam Neeson) grew up with a religious and domineering father, and as a young child he suffered from a number of serious illnesses, including rickets. As an adult Kinsey made a career as a biologist, specialising in the taxonomy of the gall wasp, but became interested in studying sex systematically after teaching "marriage" classes to his students, in which he found that he was not always able to answer their many questions about sex. He was, and still is, considered radical as a researcher for dismissing the idea of normality and instead describing the "common" or the "rare." His attempts to welcome sexual diversity, in particular acknowledging homosexuality, simultaneously paved the way for greater freedoms for gays and bisexual men and women but led to hostile criticism of Kinsey.
Those who have done health research, but especially anyone who has studied sex, will enjoy watching interviews being recreated and be happy to see Kinsey actively supporting his research team, taking a leading role in interviewing participants, reviewing how best to take a sexual history, and training colleagues to collect data.
More surprising is the blurring of boundaries between some of Kinsey's work and his personal life, in particular his sexual relationship with a male research colleague; his unconventional marriage to Clara (played superbly by Laura Linney); and the frank discussions of sex with his family, including taking his father's sexual history.
Those who work in sexual health will find some moments of the film very poignant-particularly researchers who have struggled to get funding because of their research topic, had their work devalued or criticised, or been made to feel they were "unscientific" for studying sex.
The film is also interesting for a general audience, having a strong cast, beautiful cinematography, and a storyline that mixes humour, scientific interest, and humanity. It provides a powerful testament to the need for sex research and a greater acceptance of sexual diversity.
And it's very relevant. In the United States currently the religious right is targeting sex researchers who they feel are studying areas outside those of "traditional family values." The drug industry is keen to create and measure sexual dysfunctions in order to market products; and in the media, from which many people glean much of their information on sex, the "sex survey" is now a commonplace and much misused and misunderstood means of filling copy.
Actor John Lithgow (who plays Kinsey's father) says of Kinsey that "he got people to say things out loud, real terrifying truths, and find out they weren't so terrifying." For that he should be remembered, and this film pays a great man a great deal of respect. H arold Shipman's murderous trail has forever altered the relationship between doctors and patients in this country. A cunning and determined psychopath outwitted his patients, professional colleagues, and the police, and evaded the attention of the General Medical Council (GMC). He succeeded because his crimes were monstrous and incomprehensible to his peers and even to the necessarily jaundiced eye of the police.
Petra Boynton
Harold Shipman would, of course, have passed any appraisal of fitness to practise with flying colours. Many of his patients, despite all evidence to the contrary, remained desperately loyal to "Dr Fred," believing that he was the best doctor in the area. His bedside manner was exemplary and the quality of his clinical notes of a high standard. The only straw in the wind that could have been taken more seriously was his previous brush with the GMC for misuse of opiates. The GMC's inability to continue to monitor the situation has resulted in a number of recommendations in Dame Janet Smith's Shipman inquiry report, Safeguarding Patients: Lessons from the PastProposals for the Future, namely better monitoring of prescribing, tighter controls on controlled drugs, and revising the rules on certification of death (www.the-shipmaninquiry.org.uk/fifthreport). All these place sensible checks in the system, which will pick up an abnormal pattern earlier.
The public, quite rightly, wish to know that there is an effective system of regulation to protect them from murderous or incompetent doctors. The question for society is what combination of carrot and stick will generate well trained, sensible, and effective physicians, aware of their limitations, able to engage in constructive self criticism and yet able to instil confidence in their patients.
By nature of their calling, most doctors are intelligent, self motivated, and altruistic. Any system of revalidation should positively motivate doctors to perform even better, while identifying individuals with difficulties. Monitoring is more likely to be effective when remedial measures are largely educational and supportive. Unfortunately, supportive measures inevitably attract the charge of protectionism, while the big stick of the GMC, wielded frequently as Dame Janet recommends, would engender fear, paralysis, disillusion, and even suicide among doctors who may not be at fault, and may be lost to the workforce as a result of their experience.
A huge amount of effort has already gone into modernising self regulation: this country is already further advanced than any of our European counterparts. The National Clinical Assessment Authority (NCAA), after a prolonged gestation, is managing to identify problem doctors early, institute remedial training, and return most of them to useful clinical activity quickly while weeding out those requiring further attention from the GMC. This is done in the absence of a blame culture, which permits openness and honesty. It allows fellow professionals to express their concerns in the knowledge that their colleagues' practice will be looked at objectively as a whole rather than focusing on one serious error, which any practising clinician will recognise at some stage in his or her own career. The NCAA is by far the best route to the identification and rehabilitation of underperforming doctors and should be strengthened.
When patients, colleagues, employers, or the NCAA identify clear suspicions of serious professional misconduct it is important to launch a swift, decisive, and transparent investigation. This should deal promptly with malicious or spurious complaints, yet fully investigate more dangerous situations. Dame Janet correctly points out that the GMC cannot act as both prosecutor and judge. However, the royal colleges, with their vast experience of the standards expected from a member of their specialty, could be used in a similar way to the Crown Prosecution Service, to decide whether there was a case to answer, applying the equivalent of the "Bolam test" (by which a doctor is judged not negligent if a responsible body of medical opinion says his or her practice was acceptable at the time) to recommend trial by the GMC if there was sufficient evidence of serious professional misconduct. Dame Janet recommends agreeing standards, criteria, and thresholds for serious professional misconduct. This would be a mistake, as criteria change rapidly in a world of advancing technology and shifting morality. The evolutionary common law system of this country is well suited to allowing a respected body of professional men and women, in partnership with lay assessors, decide, using current accepted standards of practice, whether there is a prima facie case to answer. Their decision should be open to public scrutiny. Only if the assessors decide there is a case to answer should the doctor's details be made public.
When the evidence indicates a doctor should appear before a conduct panel, a college assessor could present the case for the "prosecution." The doctor would be represented by his or her defence organisation, and a panel of medically qualified and lay judges would be provided by the GMC. The standard of evidence should remain "beyond all reasonable doubt" where erasure from the register is at stake. The profession has nothing to fear either from the medical judges being appointed, rather than elected, or from lay judges.
Revalidation by summative annual appraisal, with its sometimes mind-numbing tick box approach, is rightly perceived by Dame Janet to be ineffective in identifying underperforming doctors. Surely as a profession we can do better. There have already been difficulties in identifying and training adequate numbers of general practice appraisers and the time lost from clinical practice in implementing a universal scheme is significant. High quality educational events, creating challenging clinical scenarios, objectively assessed could provide the answer. These could be used in a similar fashion to a pilot undergoing routine simulator training. At the end of the experience, doctors should feel stretched and stimulated to fill gaps in their knowledge. Those few not reaching the grade would be able to receive further educational support or limit their practice appropriately. Completing practical, measurable assessments in this way would be more acceptable to the general public than an appraisal in private by another doctor.
Former BMJ editor Richard Smith is correct in his analysis that a minimalist approach to the conundrum of revalidation and regulation will not succeed (BMJ 2005; 330:1-2) . However, an imposed solution that fails to capture the imagination and aspirations of the profession will leave both doctors and patients the poorer. This is a time for creativity and positive thinking to enable us to find a solution to restore the faith of the British public in their doctors and that of the British medical profession in their leaders.
A US model for primary care in the NHS I n July 2001 I began a year working in a primary care trust in east London. My career had already taken me from Canada, where I trained, to the United States, where I worked for 20 years in a community health clinic. There we served a medically indigent population, including refugees and new immigrants of Asian, African, and Latin and South American origin. In going to England I was eager to return to a country with socialised medicine and to compare the NHS's ability to provide care for a community with a similar low socioeconomic profile. To this end I became the lead person for cardiovascular health promotion in Tower Hamlets for a year.
Our centre in San Diego, one of 10 000 non-profit, community based health centres across the country, provides care for adults and children, comprehensive family planning, gynaecological services (including colposcopy), mental health services, smoking cessation counselling, and health promotion. Funding comes from payments from patients, fee-for-service billing, managed care billing, and government grants. Care is provided in seven languages with the help of professional interpreters, who are also trained as medical assistants. In the pre-examination they document descriptions of any chief complaint, take vital signs, and anticipate physicians' needs by carrying out eye examinations, coordinating glucose measurements, and performing urinalysis and pregnancy tests.
The mission of the San Diego family care centre is to maximise its limited resources to provide high quality health care to a poor population. The centre uses treatment "pods" consisting of six fully equipped examination rooms with examination tables, ophthalmoscopes, otoscopes, wall mounted blood pressure cuffs, and all the supplies that healthcare practitioners might need to obtain routine specimens. The providers include physicians, nurse practitioners, and physician assistants. One treatment room in each pod includes an electrocardiograph, minor surgical equipment, respiratory treatment equipment, and a fully equipped crash cart for emergencies. A nurse is assigned to the central station of each pod and provides support, triage, and technical and dispensary services for all six examination rooms. An onsite clinical laboratory provides immediate results for services such as pregnancy tests, urinalysis, wet mounts, streptococcus screening, and glucose and haemoglobin determinations. The results from outsourced laboratory studies are reported to the centres by teleprinter, usually within 24 hours. Although the medical records are not computerised, laboratory results, pharmacy records, billing, scheduling, and case management are available to staff on line.
Several glaring differences became apparent after I talked to GPs in their practices and to NHS employees in east London. East London's primary care system was severely challenged by the physical premises where GPs practise. There was also a noticeable absence of any ancillary support staff, such as medical and laboratory assistants or nurse practitioners. I witnessed triaging out of basic services, including primary care complaints referred to specialists, which is understandable, given the lack of time and support reported by the GPs. The excellent computerised medical records system was not being used to monitor patients for the preventive services suggested by international groups such as the Cochrane Collaboration and the US Preventive Services Task Force. The auditing system was poorly coordinated with the primary care offices, making quality improvement difficult. Using the model of the US community health clinic, the NHS could make simple and inexpensive changes to improve outcomes, without increased spending. GPs would be relieved of low level tasks that could be accomplished by medical assistants. Medical assistants (who in the United States undergo a six month certificate programme) could be trained to measure vital signs, thereby reducing the high rates of undetected hypertension in England, provide medical translation (thereby increasing the quality of the GP-patient interaction), and perform minor procedures like venepuncture and electrocardiography. Either medical assistants or minimally trained laboratory assistants could provide basic laboratory services. With the extra time available in the "nine minute visit," the GP practices could absorb the roles of some of the specialty care, but perhaps even more importantly they could provide more preventive care and health promotion. Nurse practitioners could help doctors with problems that lend themselves to clear protocols. Through auditing, standardised quality control and assurance, and specific NHS support of ancillary licensed and certified healthcare providers in general practices, the NHS could look towards long term cost benefits and extended quality of life. California, San Diego lhillbaird@aol.com The NHS could make simple and inexpensive changes to improve outcomes
Linda Hill clinical professor, department of family and preventive medicine, University of
SOUNDINGS
Seeing things
A few months back, I couldn't shake off a chest infection. I self medicated with amoxycillin and then consulted my general practitioner, who prescribed a second line antibiotic. I swallowed the first tablet there and then, and drove on to work.
I remember thinking it strange that the road ahead was covered in shimmering patches of the kind you see on long straight roads in the heat of summer. After all, it was the North Circular Road in November.
A black cat with a shimmering tail leapt out into the road from my left, sprang across to the opposite pavement, and then disappeared behind a bus queue. One of his nine lives.
A few yards farther on, a black cab pulled out from a side road and cut right across me. It changed direction in the middle of the road, and pulled neatly into a parking space on the opposite side. I turned my head to give the driver a dirty look. No black cab-and no parking space.
I pulled into a lay-by and scanned the solid skyline of London rooftops as a seasick sailor might fix her dizzy eyes on the horizon. A black figure in a shimmering cloak leapt deftly from chimney to chimney. Batman. So he was in this too. He and the shimmering spider that was making its way across my windscreen.
Having seen what I saw, I suspect that the physiological mechanism was some sort of short circuiting of the cone cells in my retina, producing black blodge signals that my occipital cortex did its best to convert to complex images. My medical record is now flagged with an idiosyncratic reaction to the antibiotic. The British National Formulary already lists "hallucinations" as a known side effect.
Most powerful drugs have a long list of rather bland adverse effects like "loss of taste," "skin reactions," "abdominal cramps," and the like. Would richer descriptions help us detect these earlier? Many of the victims of paroxetine withdrawal described a sensation of "electric head," which was logged by the Medicines Control Agency as "paresthesiae," thereby losing the essence of its distinctiveness. Isn't it time someone set up a Database of Unlikely Sensations in Takers of Medicines with a view to systematically capturing the symptoms we should be warning our patients to look out for?
Trisha Greenhalgh professor of primary health care, University College London reviews
